Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors

✍ Scribed by Molife, L. Rhoda; Rudman, Sarah M.; Alam, Salma; Tan, Daniel S.-W.; Kristeleit, Hartmut; Middleton, Gary; Propper, David; Bent, Liz; Stopfer, Peter; Uttenreuther-Fischer, Martina; Wallenstein, Gudrun; de Bono, Johann; Spicer, James

• Book ID: 121602458
• Publisher: Springer
• Year: 2013
• Tongue: English
• Weight: 697 KB
• Volume: 72
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-013-2286-7